Author: Dorron Blumberg

NICKLAUS CHILDREN’S OFFERS COVID-19 VACCINE TO AT-RISK CHILDREN AND YOUNG ADULTS

Posted by | Mar 5, 2021 | |

March 5, 2021 – Nicklaus Children’s Hospital has announced availability of the Pfizer-BioNTech vaccine for Florida’s children and young adults ages 16 to 21 who are currently under the care of physicians or specialists for medical conditions identified by the Centers for Disease Control (CDC) as posing an increased risk for severe illness associated with COVID-19.

Read More

HIE Networks Relaunches as Centralis Health

Posted by | Mar 5, 2021 | |

Leading health information exchange provider rebrands and expands services offerings
to reflect company’s expansion and commitment to improving community health
 
March 4 2021 – HIE Networks, a leading health information exchange provider, today announced the company’s complete rebranding as Centralis Health, effective immediately. The rebrand charts a clear path to the future as the company helps health care providers access, manage, and use medical data to produce the best possible patient outcomes at every step of care. The rebrand keeps the core team and strong company values while offering a new Centralis Health name, logo, and website with a clearly defined mission statement, vision, and values.
 

Read More

Maryland DDA Acquisition now brings Gastro Health into sixth state Two-year period of mergers & acquisitions within single-specialty gastroenterology sector shows rapid growth and expansion

Posted by | Mar 5, 2021 | |

March 5, 2021 – Gastro Health, a national leading medical group specializing in digestive health, has partnered with Digestive Disease Associates (DDA), a gastroenterology group with two locations based in Catonsville and Columbia, Maryland. This partnership also includes the state-of-the-art endoscopy center, Howard County Gastrointestinal Diagnostic Center, and two infusion centers.

Read More

Holy Cross Health to Offer Valves for the Lungs as a New Treatment Option for Patients with Severe COPD/ Emphysema

Posted by | Mar 5, 2021 | |

Revolutionary lung valve is the first FDA-approved device  to help
emphysema patients breathe easier without major surgery  
 
March 5 2021 –  Holy Cross Health is one of the first in South Florida to offer a new lung valve treatment for patients with severe COPD/emphysema.  
 
Recently approved by the FDA under its “Breakthrough Devices” status, the Zephyr® Endobronchial Valve treatment is a major advancement because it is the first minimally invasive procedure to help emphysema sufferers breathe easier without major surgery. Through a simple bronchoscopy, the valves improve a patient’s quality of life by allowing them to breathe easier, reducing the shortness of breath, while promoting a more active and energetic lifestyle.

 

Read More